UV toxicity culprit in post-LASIK dry eye

Article

Hypoesthesia is not the origin of post-LASIK punctuate epithelial keratopathy or the so-called dry eye syndrome. Rather, these sequelae may represent a phototoxic effect of treatment with the ultraviolet excimer laser, said Carmen Barraquer-Coll, MD.

Hypoesthesia is not the origin of post-LASIK punctuate epithelial keratopathy or the so-called dry eye syndrome. Rather, these sequelae may represent a phototoxic effect of treatment with the ultraviolet excimer laser, said Carmen Barraquer-Coll, MD.

"In our surgical and clinical experience we have never seen dry eye in recipients of penetrating or lamellar grafts or in eyes that have undergone freezing keratomileusis, epikeratophakia, planar keratomileusis, or in situ keratomileusis with and without a hinge. Nor have we found any publications on the so-called dry eye syndrome after these procedures," observed Dr Barraquer-Coll, head, refractive surgery department, Barraquer Clinic, Bogota, Colombia.

"Like LASIK, these are all corneal surgeries associated with nerve sectioning or tissue denervation," Dr Barraquer-Coll said. "Use of the excimer laser is the most obvious answer to the question of what is the difference between LASIK and these corneal surgeries."

Dr Barraquer-Coll hypothesized that every pulse of the laser produces an equal area of collateral damage. In addition, through a reaction with ambient oxygen, there is the potential for release of ozone.

This concept is being investigated in a prospective open-label clinical trial where eyes were allocated to undergo LASIK with a standard technique or a protected technique involving covering of the limbus, bulbar conjunctiva, and stromal side of the flap. A preliminary analysis was performed using data from a total of 143 eyes. The two surgical groups were nearly equally represented, and they were similar with respect to gender, age, preoperative Schirmer II and tear breakup time results, defocus, and total ablation depth.

In logistic regression analysis, eyes operated on with the protected technique had an approximately 70% lower risk of dry eye syndrome postoperatively. Females had a threefold greater risk than males.

 

Read

ASCRS 2008 meeting highlights.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.